Results 311 to 320 of about 6,410,935 (343)

A minimally cytotoxic CD4 mimic as an HIV entry inhibitor.

Bioorganic & Medicinal Chemistry Letters, 2016
Takaaki Mizuguchi, S. Harada, T. Miura, Nami Ohashi, T. Narumi, Hiromi Mori, Yu Irahara, Yuko Yamada, Wataru Nomura, S. Matsushita, K. Yoshimura, H. Tamamura   +11 more
semanticscholar   +1 more source

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2021
exaly  

Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy

AIDS (London), 2016
Wen Li, Fei Yu, Qian Wang, Qian-Qian Qi, Shan Su, Lan Xie, Lu Lu, Shi-Bo Jiang   +7 more
semanticscholar   +1 more source

Immune Checkpoint Inhibitors May Be Safe for Patients With Preexisting Autoimmune Disease

Ca-A Cancer Journal for Clinicians, 2020
Mike Fillon
exaly  

Virus Entry Inhibitors

2022
openaire   +1 more source

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

Journal of Hepatology, 2013
T. Volz, L. Allweiss, M. Ben MBarek, M. Warlich, A. Lohse, J. Pollok, A. Alexandrov, S. Urban, J. Petersen, M. Lütgehetmann, M. Dandri   +10 more
semanticscholar   +1 more source

HCMV ENTRY INHIBITORS

2018
SINZGER CHRISTIAN, LAIB SAMPAIO KERSTIN, STEGMANN CORA, ADLER BARBARA   +3 more
openaire   +3 more sources

A CD4 mimic as an HIV entry inhibitor: pharmacokinetics.

Bioorganic & Medicinal Chemistry, 2013
Chie Hashimoto, T. Narumi, Hiroyuki Otsuki, Yuki Hirota, Hiroshi Arai, K. Yoshimura, S. Harada, Nami Ohashi, Wataru Nomura, T. Miura, T. Igarashi, S. Matsushita, H. Tamamura   +12 more
semanticscholar   +1 more source

Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor.

Bioorganic & Medicinal Chemistry Letters, 2012
G. Mittapalli, Fang Zhao, Andrew Jackson, Hong-Feng Gao, Haekyung Lee, Stephine Chow, M. Kaur, Natalie N. M. Nguyen, R. Zamboni, J. Mckelvy, F. Wong-Staal, James E. Macdonald   +11 more
semanticscholar   +1 more source

Poly(ADP-Ribose) Polymerase (PARP) Inhibitors: Exploiting a Synthetic Lethal Strategy in the Clinic

Ca-A Cancer Journal for Clinicians, 2011
Johann de Bono, Timothy A Yap, Shahneen K Sandhu   +2 more
exaly